Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
56.71B | 54.83B | 51.05B | 48.65B | 45.48B | 52.49B | Gross Profit |
8.34B | 8.01B | 7.06B | 6.58B | 5.88B | 10.64B | EBIT |
2.26B | 2.37B | 1.88B | 1.53B | 1.10B | 1.26B | EBITDA |
3.05B | 3.20B | 3.42B | 3.08B | 2.66B | 2.68B | Net Income Common Stockholders |
1.15B | 1.17B | 103.00M | 1.08B | 791.00M | 1.09B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.38B | 6.98B | 6.63B | 5.48B | 4.68B | 3.03B | Total Assets |
30.63B | 30.43B | 30.38B | 30.94B | 30.35B | 30.02B | Total Debt |
6.46B | 7.26B | 8.54B | 9.15B | 9.63B | 9.77B | Net Debt |
78.00M | 281.00M | 1.91B | 3.67B | 4.95B | 6.74B | Total Liabilities |
14.83B | 15.48B | 16.35B | 16.75B | 16.93B | 17.22B | Stockholders Equity |
15.79B | 14.95B | 14.03B | 14.18B | 13.42B | 12.79B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.96B | 1.96B | 1.66B | 1.88B | -2.75B | Operating Cash Flow |
0.00 | 3.67B | 2.97B | 2.59B | 3.17B | 1.67B | Investing Cash Flow |
0.00 | -1.70B | -940.00M | -998.00M | -1.20B | -3.91B | Financing Cash Flow |
0.00 | -1.62B | -879.00M | -792.00M | -320.00M | 795.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥23.87B | 12.71 | ― | 16.73% | 80.15% | ||
75 Outperform | ¥16.23B | 10.63 | 2.88% | -5.97% | -37.27% | ||
68 Neutral | ¥13.87B | 14.80 | 2.22% | 5.15% | -13.31% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
64 Neutral | ¥14.38B | 17.19 | 1.54% | 0.59% | -15.61% | ||
58 Neutral | ¥12.11B | 208.06 | 1.38% | 10.29% | -52.95% | ||
56 Neutral | ¥13.34B | 25.04 | 0.31% | -2.04% | ― |